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We are grateful to Dr Olsson for his comments [1] about
the recently published ‘EACTS/ESCVS best practice guide-
lines for reporting treatment results in the thoracic aorta’,
[2] which nevertheless deserve a reply. It is true that the
EACTS/ESCVS working group tried to create a concise
document, as distinct from all encompassing, large ‘Expert
consensus document on the treatment of descending thoracic
aortic disease using endovascular stent-grafts’. [3] We would
contend, however, that the shortcomings of the guidelines
are not ‘counter-productive’, but, rather, move us closer to
standardisation of information provided in the published
reports of outcomes after thoracic endovascular repair
(TEVAR) intervention. Our systematic review of the TEVAR
literature detected disconcerting variability in the quality of
information in the published reports. Without a concerted
effort to achieve at least an agreed upon basic outlay of data
regarding patient characteristics, techniques applied and
outcomes observed, our efforts to monitor progress in the
field of surgery and to improve patient outcomes will be
thwarted.
As stated, the purpose of the guidelines was to ‘provide a
standard format for reporting results of treatment in the
thoracic aorta . . .’ and was not intended to guide decision
making about whether to operate or to apply conservative
medical management for patients with disease of the
descending thoracic aorta. With this in mind, the guidelines
will be intentionally applicable only for the reporting of
outcomes and patient characteristics after interventional
treatment has been applied. Therefore, many of the
comments provided by Dr Olsson will not be applicable for
defining minimal guidelines for the published reports of
TEVAR interventions.
We appreciate that the list of major diseases of the
thoracic aorta is a mix of functional diagnoses and
aetiologies, but it was shown to be necessary, given the
imperfect categorisation of TEVAR in real life. The categories
listed represent an improvement upon the level of detail
provided in many reports to date. We had discussed whether
rupture and penetrating aortic ulcer warranted their own
categories, but came to a consensus that these were better
subsumed under their aetiologic categories.
Dr Olsson raises an important issue regarding European
system for cardiac operative risk evaluation (EuroSCORE) and
its lack of tested validity for TEVAR intervention. We are, of
course, well aware of the nature of EuroSCORE and its
development as a primary assessment tool for the results of
coronary bypass grafting. We are not proposing that Euro-
SCORE should be used to determine who receives surgical
versus conservative management or to predict major
outcomes in TEVAR. In spite of its coronary origin, EuroSCORE
is widely used for analysing the emerging results of
percutaneous and transapical aortic valve replacement. [4]
Furthermore, many of the acknowledged risk factors for
surgical correction of thoracic aortic aneurysms, such as age,
left ventricular function, peripheral vascular disease,
neurological dysfunction, chronic pulmonary disease and
others, form part of the logistic and additive EuroSCORE.1
Therefore, we are simply proposing that authors should
provide the EuroSCORE at baseline in their reports as a broad
indicator of baseline risk, since EuroSCORE is still the most
commonly used system for scoring in cardiothoracic surgery.
In the absence of better systems [5] and until a disease-
specific system is developed for aortic aneurysms [6], we
would like to see more consistency in providing the Euro-
SCORE at baseline in the published reports.
Future updates of these guidelines may include more
definitive requirements for description of adjunctive tech-
niques, particularly if the evidence supports the relative
impact of these adjuncts. However, EACTS/ESCVS guidelines
have been developed to be practical and for easy application.
These guidelines could be certainly improved in future;
however, meanwhile, they represent the first step to address
the issue of reporting the treatment results in TEVAR.
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